NOT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Novartis AG

Watchlist Manager

Watchlist

Price: 123.58 EUR -0.53% Market Closed

Market Cap: €254B

N	Novartis AG XMUN:NOT	CH
D	DBV Technologies SA F:DBV	FR
	Monopar Therapeutics Inc F:1IY	US
	Alpha Services and Holdings SA F:ACBC	GR
T	Terex Corp XMUN:TXG	US
E	Endeavour Silver Corp XMUN:EJD	CA
F	F5 Inc XMUN:FFV	US
B	Banco Bilbao Vizcaya Argentaria SA XMUN:BOY	ES
V	Vistra Corp F:0V6	US
G	Galapagos NV F:GXEA	BE

Profitability Summary

Novartis AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

75%

Strong 3Y Average Gross Margin

75%

Gross Margin is Increasing

73% > 75%

Exceptional Operating Margin

32%

Sustainable 3Y Average Operating Margin

28%

Operating Margin is Increasing

23% > 32%

Healthy Net Margin

24%

Sustainable 3Y Average Net Margin

25%

Net Margin is Increasing

17% > 24%

Exceptional Free Cash Flow Margin

28%

Strong 3Y Average Free Cash Flow Margin

27%

Free Cash Flow Margin is Increasing

24% > 28%

Exceptional ROE

35%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

14%

ROIC is Increasing

11% > 16%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.